Drug Pipeline

CD4CAR Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06197672 Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory… Acute Myeloid Leukemia Recruiting
NCT06071624 Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line… Chronic Myelomonocytic Leukemia Recruiting
NCT03829540 CD4CAR for CD4+ Leukemia and Lymphoma T-cell Lymphoma Recruiting
Sponsors Running CD4CAR Trials
Huda Salman (3)
Disease Areas
Leukemia (3) Acute Myeloid Leukemia (AML) (1)
Get alerts when CD4CAR trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free